Ultrasound contrast developer Acusphere has priced a public offering of 900,000 shares of its 6½% convertible exchangeable preferred stock.
The Watertown, MA-based firm estimated it will receive net proceeds of approximately $41.5 million, after deducting underwriting discounts and commissions and estimated offering expenses.
By AuntMinnie.com staff writers
February 18, 2005
Related Reading
Acusphere taps new VP, January 25, 2005
Acusphere closes financing, October 25, 2004
New financing for Acusphere, October 18, 2004
Acusphere adds to coffers, August 3, 2004
Acusphere leases manufacturing facility, July 23, 2004
Copyright © 2005 AuntMinnie.com